Women who undergo menopause before the age of 40 are more likely to experience cognitive decline, which may lead to dementia, ...

The complete response letter did not identify any issues with the safety or efficacy of Eylea HD, Regeneron officials said.

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Having a child recipient and helping someone in need – especially if they knew them – were among the top reasons that people ...

Republicans are aiming for major reductions in federal spending, and Medicaid seems a likely target. But the politics of ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

The analysis from the Urban Institute breaks down projected coverage losses across the 40 Medicaid expansion states, where ...

Panelists discuss how, cemiplimab, a PD-1 inhibitor, has shown promise as a second-line therapy for advanced NSCLC after ...

In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains ...

Panelists discuss how, as new data on cemiplimab and other checkpoint inhibitors emerge, the treatment pathway for cancers ...

A trial found magnetic resonance imaging correlated with physical function tests in patients with Duchenne muscular dystrophy ...

The CEOs of CVS Health and UnitedHealth Group praised pharmacy benefit managers and promised transparency during investor ...